BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has been granted a Japanese patent for an application that includes claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation. The patent is titled "Inclusion of Apoptotic Regulators in Solutions for Cell Storage at Low Temperature," and BioLife was previously granted US and European patent protection for this intellectual property.
Mike Rice, BioLife's chairman and CEO, noted the new patent is a direct result of BioLife's ongoing efforts to increase the value of its intellectual property portfolio and enable additional product and licensing revenue streams for BioLife. "In addition to this granted Japanese patent, two international Patent Cooperation Treaty (PCT) applications were recently published covering claim sets related to the collection, storage, transport, and banking of whole blood and also birth tissue including cord blood. I'm pleased that our research and development activities continue to produce discoveries and potential innovations in the biopreservation field."
Red light therapy shown to significantly reduce blood sugar spikes, study finds